The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bioimpact Capital Llc since 2020.
This trader's CIK number is 1687078.
At the time of last reporting, Bioimpact Capital Llc was the 10% Owner of Cullinan Oncology, Inc.. (stock ticker symbol CGEM).
Also see all insider trading activities at Cullinan Oncology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CGEM | 300,000 | $6,300,000 | 265,619 | $7,773,810 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ONCR | 151,224 | $2,268,360 | 0 | $0 | 0 | $0 |
1. Cullinan Oncology, Inc. (CGEM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-09-16 | CGEM | Sale | 3,124 | 29.06 | 90,783 |
| 2021-09-14 | CGEM | Sale | 7,106 | 29.17 | 207,282 |
| 2021-09-15 | CGEM | Sale | 6,425 | 29.16 | 187,353 |
| 2021-09-13 | CGEM | Sale | 3,595 | 29.10 | 104,614 |
| 2021-09-10 | CGEM | Sale | 5,931 | 29.04 | 172,236 |
| 2021-09-09 | CGEM | Sale | 13,727 | 29.35 | 402,887 |
| 2021-09-07 | CGEM | Sale | 25,067 | 29.04 | 727,945 |
| 2021-09-08 | CGEM | Sale | 10,842 | 29.11 | 315,610 |
| 2021-09-03 | CGEM | Sale | 12,731 | 29.60 | 376,837 |
| 2021-09-01 | CGEM | Sale | 5,714 | 29.47 | 168,391 |
| 2021-09-02 | CGEM | Sale | 15,757 | 29.46 | 464,201 |
| 2021-08-31 | CGEM | Sale | 2,838 | 29.79 | 84,529 |
| 2021-08-27 | CGEM | Sale | 13,357 | 29.09 | 388,555 |
| 2021-08-30 | CGEM | Sale | 31,001 | 29.30 | 908,329 |
| 2021-08-25 | CGEM | Sale | 1,713 | 29.09 | 49,831 |
| 2021-08-24 | CGEM | Sale | 50,822 | 29.48 | 1,498,232 |
| 2021-08-23 | CGEM | Sale | 53,359 | 29.11 | 1,553,280 |
| 2021-08-11 | CGEM | Sale | 2,510 | 29.05 | 72,915 |
| 2021-01-12 | CGEM | Buy | 300,000 | 21.00 | 6,300,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-10-06 | ONCR | Buy | 151,224 | 15.00 | 2,268,360 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bioimpact Capital Llc (10% Owner of Cullinan Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.